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Summary  
~:~epresents  the chondrocyte and its pericellular microenvironment and plays an important role in the 
~ost~•Oa~thr i t i s .  Type VI collagen is preferentially localized in the pericellular microenvironment of adult 
~ i l a g ~  ~nd increases during osteoarthritis. In this study, we characterized the pericellular sequestration 
~:~| tageh:  in long-term chondrocyte-agarose cultures, and assessed the action of interleukin-1 on type VI 
:~~~~nand~;~: ! :  ~:~:i ~ ' :  : assembly. 
~ '~~i~°emica l  and biochemical analysis showed that cultured chondrocytes initiate type VI collagen 
~rat io r t  immediately upon plating and continue pericellular matrix sequestration in a time dependent manner. 
C ~ l  m~roscopy confirmed the cell surface localization and pericellular accumulation of type VI collagen, while 
i ~  analysis identified a 'cargo-net like' organization of type VI collagen around each chondrocyte. Quantitative 
~ i s  revealed a primary phase of rapid cell division and low levels of type VI collagen sequestration, followed by 
• g~ndar~• phase of relative growth stability and high levels of type VI collagen deposition. Interleukin-1 treated 
ct t |~s  showed increased sequestration and retention of type VI collagen in an expanded microenvironment 
sur-~l~rlding the chondrocytes. 
The~data suggests a role for type VI collagen in the differentiation of the pericellular microenvironment i  vitro. 
Th~ ~¢reased type VI collagen sequestration promoted by interleukin-1 was consistent with previous studies on 
0steo~thritic cartilage, and implies a functional role for type VI collagen in the chondron remodeling associated with 
~t~ge degradation. 
K~ywords: Type VI collagen, Pericellular microenvironment, Chondrocytes-agarose culture, lnterleukin-1. 
In t roduct ion  
Tttt~i:i:~ONDRON has previously been identified as a 
• ~ C . . . . . . . . . . . . .  " dis r~ miCrOanatomical unit of adult art icular 
cartiI~g~: [1,•2]. Each chondron consists of a 
• bhor~yte  surrounded by a pericellular microen- 
~:i~onme~t••that contains collagen types II, VI, IX 
[h~iii:~| andi:i:::XI [5], the proteoglycans aggrecan and 
de~brin [6~7,8], and glycoproteins, such as 
fib~ectin:ii:i::[9] and link protein [10]. Of these 
pe~ttular i : : :components,  type VI collagen has 
eme~d a~::::a discrete molecular marker of 
ch~on m~croanatomy, interacting with both the 
cell-$~face and the heterogenous matrix com- 
ponen~::of the pericellular microenvironment [11]. 
~: :  VI collagen is widely distributed in 
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connective tissues, and is expressed in the form of 
thin, beaded filaments, structural ly distinct from 
other fibrillar collagens [12, 13]. Published studies 
indicate that the triple-helical domain of type VI 
collagen contains several Arg-Gly-Asp sequences 
involved in cell binding [14], while interactions 
with cell-surface receptors, such as the integrins 
[15] and the NG-2 receptor [16], have been reported. 
In addition, the globular domains of type VI 
collagen contain a number of repeating amino •acid 
motifs homologous with the fibrillar collagen-bind- 
ing A domain of von Willebrand factor [17] sug- 
gesting a functional interaction between type VI 
"•collagen and the heterotypic collagen fibers of the 
extracel lular matrix [18]. Type VI collagen inter- 
acts also with a range of matrix macromolecules, 
including type II collagen, decorin and fibro- 
modulin [19], hyaluronan [20], and fibronectin [21 ]. 
Ultrastructural  studies on the type VI collagen 
matrix produced by cultured fibroblasts have 
demonstrated both cell--matrix and matrix- matrix 
interactions, while light, confocal and electron 
microscopic analyses of isolated canine chondrons 
have confirmed that type VI collagen interacts 
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directly with the chondrocyte membrane, and 
extends outward from the cell surface to define the 
structural heterogeneity of the chondron [3, 11]. It 
is likely, therefore, that type VI collagen performs 
a bridging function in articular cartilage, not only 
between the chondrocyte and its pericellular 
matrix, but also between the spatially integrated 
matrix macromolecules of the pericellular mi- 
croenvironment. 
Interleukin-1 (IL-1) is a critical mediator of 
cartilage catabolism during osteoarthritis [22], and 
has consistently been shown to down-regulate 
proteoglycan and collagen production in isolated 
chondrocyte and cartilage explant cultures 
[22, 23]. Simultaneously, IL-1 increases the degra- 
dation of these components by up-regulating the 
production of matrix metalloproteinases such as 
stromelysin and collagenase, but not the tissue 
inhibitors of the metalloproteinases (TIMPs) 
[24, 25, 26]. Interestingly, type VI collagen appears 
resistant o metalloproteinase attack [26, 27], and 
higher levels of type VI collagen with a broad 
pericellular distribution have been reported in 
osteoarthritic artilage [28, 29, 30]. 
Because there are currently no reports on the 
pericellular assembly of type VI collagen by 
chondrocytes, we have used confocat immunohisto- 
chemistry and specific analytical techniques to 
characterize the progressive pericellular seques- 
tration of type VI collagen during long-term 
agarose gel culture of adult articular chondro- 
cytes. The modulation of type VI collagen assembly 
by IL-1 was also examined, and shown to promote 
significant increases in pericellular type VI 
collagen sequestration, which parallels the mi- 
croanatomical changes in type VI collagen which 
have been reported for osteoarthritic artilage. 
Mater ia ls  and methods  
MATERIALS 
Hams F-12 culture medium, fetal bovine serum 
(FBS) and bovine serum albumin (BSA) were 
obtained from GIBCO, Life Technologies, New 
Zealand. Sea plaque agarose was obtained from 
FMC Bioproducts U.S.A. Pronase, and human 
recombinant IL-I~ in the form of a sterile solution, 
were obtained from Boehringer Mannheim, New 
Zealand, while collagenase and testicular 
hyaluronidase were obtained from Sigma Chemical 
Co., U.S.A. Cell Tracker Green (5-chloromethyl- 
fluorescein diacetate) and ethidium homodimer-1 
were obtained from Molecular Probes, OR, U.S.A. 
The ECL western blotting detection kit was 
purchased from Amersham , U.K. Anti-type VI 
collagen antibody was kindly donated by Dr 
Shirley Ayad, School of Biological Science, 
University of Manchester, U.K. 
ISOLATION OF CHONDROCYTES AND AGAROSE GEL 
CULTURE 
Fresh cartilage samples were collected through 
the full depth of the tibial plateaus and femoral 
condyles of mature, healthy crossbred dogs (2-4 
years; 20-25 kg) euthanized by the Auckland City 
Pound under veterinary supervision. Cartilage 
samples were pooled and chondrocytes i olated as 
previously described [31]. Briefly, diced cartilage 
was treated with pronase (0.8% w/v, at 37°C for 
90 min) in Ham's F-12 medium containing 5% FBS, 
followed by bacterial collagenase digestion (0.4% 
w/v, at 37°C for 19h) in Ham's F-12 medium 
containing 5% FBS. Once digested, cells were 
centrifuged and washed in medium, and total cell 
number determined by hemocytometer counting. 
Cells were suspended in a solution of 1% (w/v) 
agarose in Ham's F-12 medium with 10% FBS at a 
density of 1 x 106 celts/35 mm dish and maintained 
in culture at 37°C for up to 12 weeks. 
To assess the effects of IL-1 on type VI collagen 
sequestration, cultures in the early stage of 
incubation (3-17 days) were used because type VI 
sequestration was shown to be low and reasonably 
constant during this period. IL-I~ was added 
directly to the culture medium at concentrations of
0.5 and 5.0 ng/ml, and the media replaced daily. 
Triplicate cultures from each treatment regime 
were collected at selected time points (3, 7, 14 
days). One culture was immediately treated with 
25#M/ml cell tracker green at 37°C for 2h  to 
stain viable cells, washed and then fixed in 4% 
paraformaldehyde for 30 min [32]. After washing, 
chondrocyte-agarose plugs were cored from the 
centre of the culture dish as previously described 
[7], and stored in phosphate-buffered saline (PBS) 
containing 1% BSA and 0.05% azide at 4°C for 
subsequent immunohistochemistry. The remaining 
two cultures were analyzed biochemically for type 
VI collagen. 
IMMUNOHISTOCHEMISTRY 
The immunohistochemical techniques for stain- 
ing type VI collagen in chondron-agarose plugs 
have previously been published [7, 11]. In this 
study, chondrocyte-agarose plugs were digested 
with testicular hyaluronidase (2mg/ml in 0.1 
Tris saline, pH 5.5, at room temperature for 60 min) 
to remove proteoglycans that otherwise mask 
antigenic sites on the type VI collagen molecule. 
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Antl-type ~pe VI collagen antibody was prepared 
at~&~•~h~on f 1.~500 in 0.1 M Tris saline with 1% 
~ ~e plugs labeled for 24-48 h at 4°C with 
~ s  agitation. Treatment with normal 
~ :  was used as a control. A biotinylated 
~ ~i rabb i t  antibody and streptavidin- 
~ ~ i R e d  were used for detection. Labeled 
i ~  ~:~qu i ! ib ra ted  and mounted in Vecta- 
i ~  ~ r  L~ib0ratories, CA, U.S.A.), and the 
i ~ i ~  ~he coverslip sealed with clear nail 
CONFOCAL MICROSCOPY 
~ VI collagen distribution in chondro- 
~ s e  •plugs was examined using a Leica 
~~S•4d confocal aser scanning microscope 
~•: :•  a krypton-argon laser (Leica, Heidel- 
~ , :G :e~many) .  Single optical sections approxi- 
~]y  0i5 #m thick were collected at intervals of 
1-p,m through the z-axis of each cell, and the 
z~eries data sets stored on magneto-optical disks. 
These data sets were processed in one of two ways 
using the Leica ScanWare software, which oper- 
ates the confocal microscope. Single optical 
sections were selected from the mid-region of the 
cell and used for image assessment and densitomet- 
tic analysis. Alternatively, z-series projections 
were• constructed which represent computer aver- 
aged assemblies of selected optical sections in the 
data set, and result in a perfectly focused image 
through the depth of the specimen. Images for 
publication were cropped, calibrated and labeled 
in Adobe Photoshop 2.5.1 and transferred to 
PageMaker 4.0.1 for assembly of the final plate 
which was printed on a Techtronix Phaser 440 dye 
sublimation printer. 
IMAGE ANALYSIS 
Image analysis was used to establish a semi- 
qua~ntitative profile of type VI collagen labeling 
in t~ i ty .  To assess the surface distribution of type 
VI collagen, a z-series projection of half the images 
in a data set was prepared, and transferred to NIH 
Image shareware for processing using a surface 
plot module of the program. Additional intensity 
profile densitometry was performed on single 
optical sections from the mid-region of the cell to 
clarify •the circumferential distribution of type VI 
collagen in the vicinity of the chondrocyte. 
CELL DENSITY ANALYSIS 
To assess cell density, three chondrocyte- 
agarose plugs were sampled from the center of 
fixed cultures at each specified time point, and 
stained for 1 h with 4 ZM ethidium homodimer in 
Dulbecco's PBS. Three areas from each plug were 
randomly selected and photographed at a constant 
magnification using a Nikon Diphot inverted 
microscope fitted with an epi-illuminated fluor- 
escein isothiocyanate (FITC) filter set. Negative 
images were projected onto a digitizing pad, and 
the total number of cells within three defined 
regions of the field was computed using in-house 
morphometric analysis software to determine cell 
• number per unit area. 
BIOCHEMICAL ANALYSIS 
Cell-associated type VI collagen was extracted 
from the agarose gel using 4M guanidinium 
chloride, 0.05M Tris, pH7.4, 24h at 4°C [33]. 
Because this study was focused on the pericellular 
sequestration of type VI collagen during the 
development of the chondrocyte microenviron- 
ment, we did not examine the type VI collagen 
content of the culture medium. However, immuno- 
histochemical data indicates a strong retention of 
type VI collagen in the pericellular microenviron- 
ment, suggesting the media fraction was likely to 
be low. Extracted type VI collagen was analyzed 
using an immunodot-binding assay [33] modified 
for use with an ECL detection system (Amersham, 
U.K.). Serial dilutions of the cell extracts and the 
corresponding protein standard were prepared in 
Tris-buffered saline, pH 7.2, (TBS) and transferred 
in volumes of 100 ~1 onto nitrocellulose membranes 
using a BIO-DOT microfiltration apparatus (Bio- 
Rad, U.S.A.). Nonspecific binding sites on the 
membrane were blocked by incubation with 1% 
BSA in TBS for 2h  at room temperature. The 
membranes were then treated for 2h  at room 
temperature with anti-type VI collagen antibody 
diluted 1.:100 in TBS containing 1% BSA. After 
washing with 0.5% Tween 20 in TBS (TBS-T), the 
membranes were treated with the ECL Western 
blotting detection kit as described in the manufac- 
turers instructions (Amersham, U.K.). The mem- 
branes were incubated with donkey anti-rabbit Ig 
horseradish peroxidase-linked whole antibody for 
1 h, rinsed with TBS-T once for 15 min and twice 
for 5 min each, and treated with equal volumes of 
detection solutions I and II for 1 min. The 
membranes were wrapped in plastic and exposed to 
X-ray film for times ranging from 30 s to 10 rain to 
achieve an optimized signal strength. Standard 
curves were prepared using type VI collagen 
extracted from calf intervertebral disc after 
enzyme digestion with chondroitin ABC lyase 
and streptomyces hyaluronidase [34]. Protein 
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standards ranged from 20-1000 ng/dot, and the 
standard curve showed a reasonably linear 
dose-dependent profile. 
Resu l ts  
IMMUNOHISTOCHEMISTRY 
Immunolabeling and confocal microscopy re- 
vealed type VI collagen sequestered around each 
chondrocyte within 24h of plating [Fig. l(a)]. 
Initially, a stippled staining pattern was observed 
on the surface of most cells in the mixed culture 
[Fig. l(a)]. However, over time, a small proportion 
of the chondrocytes consistently failed to sequester 
type VI collagen in the pericellular microenviron- 
ment, suggesting a unique subpopulation of 
chondrocytes which express low levels of type VI 
collagen. 
After 1 week in culture, the stippled sequestra- 
tion became more uniform, single optical sections 
revealing a thin, discontinuous layer of type VI 
collagen surrounding the chondrocyte [Fig. l(b)]. 
By 6 weeks of culture, intensely stained bands of 
type VI collagen appeared woven around most 
cells, the limited staining between these bands 
creating the impression of a 'cargo-net-like' 
enclosure around the cells [Fig. 1(c)]. 
At the end of the culture period (12 weeks) 
considerable variability was observed in the 
structural organization of type VI collagen around 
individual cells. The most consistent pattern to 
emerge was a layered pattern, concentric rings of 
type VI collagen forming around many of the 
chondrocytes [Fig. l(d)]. Type IV Collagen staining 
was consistently high in a broad band immediately 
adjacent to the chondrocyte with successive layers 
showing progressively weaker staining intensities 
and increased isorganization. 
IMAGE ANALYS IS  
Analyses of surface plots from z-series projec- 
tions obtained after 1 day culture are shown in 
Fig. 2(a), (b), and il lustrate peaks of intense 
punctate staining on the cell surface with deep 
intervening trough s of minimal intensity. How- 
ever, after 6 weeks culture, a marked decrease in 
the width and depth of the troughs was clearly 
evident [Fig. 2(c), (d)], while the peaks of staining 
intensity did not increase appreciably but tended 
FIG. 1. Digital confocal images of chondrocytes cultured in agarose gel for different iine periods and labeled with 
anti-type VI collagen antibody. (a) Z-series projection of a single chondrocyte after I day in culture. A stippled pattern 
of type VI collagen staining was clearly evident on the cell surface. Bar = 10 #m. (c) A single optical section from a: 
chondrocyte cultured for 1 week illustrating the thin, discontinuous layer of type VI collagen sequestered on the cell 
surface. Bar--10 #m. (b) Z-series projection showing a single chondrocyte after 6 weeks in culture. Intensely-stained 
bands of type VI collagen create the impression of a 'cargo-net-like' enclosure woven around the cell. Bar = 10 #m. (d) 
A single optical section through achondrocyte after 12 weeks in culture showing concentric layers of type VI collagen 
with different labeling intensities. The pericellular layer adjacent to the cell surface consistently showed the strongest 
staining. Bar = 10 #m. 
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FI~. 2. Image analysis of the surface distribution of type VI collagen sequestered by chondrocytes in agarose culture. 
(a) Z-series projection of" a single chondrocyte after 1 day in culture. The square box represents he area analyzed. 
Bar= t0 tan. (b) Surface plot analysis of (a) revealed peaks of intense punctate staining on the cell surface with deep 
intervening troughs of minimal intensity. (c) Z-series projection of a single chondrocyte after 6 weeks in culture 
showing the area analyzed. Bar = 10 tun. (d) Surface plot analysis of C showing that peaks of staining intensity tended 
to coalesce and form ridges of type VI collagen labeling over the cell surface. 
to coalesce to form ridges of intense labeling over 
the cell surface [Fig. 2(d)]. By the end of the 
cult.ure period a uniform intensity was achieved 
around the cell with the remaining troughs 
presenNng as broad and shallow depressions 
(r e sul~s :ii::i::~0 t. shown). 
Dens~tometric analysis of the intensity profiles 
obtaine~.. ~rom single optical sections revealed a 
thin banit Ofdense staining on the cell surface after 
I. week's e~lture, while two or. three concentric 
peaks of.pt:0gressively weaker density were evident 
after 12 .weeks' culture (results not shown). 
CELL  DENSITY  
Changes in chondrocyte density during the 
culture period are shown in Fig. 3. During the first 
2--3 weeks of the culture, chondrocyte density 
doubled, indicating a primary phase of rapid cell 
proliferation. However, over the remaining 9 10 
weeks of culture chondrocyte density stabilized, a
10 20% increase in cell density indicating a 
secondary phase characterized by a marked 
reduction in the rate of chondrocyte proliferation. 
Total cell numbers increased 2.6 times during the 
12-week culture period. 
BIOCHEMICAL  ANALYS IS  
]'he immunodot binding analysis of cell associ- 
ated type VI collagen is presented in Fig..4. 
Clearly, adult ehondroeytes sequestered type VI 
collagen in a time dependent manner, character- 
ized also by two distinct phases of activity. In the 
first month of culture, the rate of type VI collagen 
deposition was low, while the later 2 months 
were characterized by a steady increase in the 
rate of type VI collagen sequestration. By the end 
of the culture period (12 weeks), the pericellular 
deposition of type VI collagen increased fivefold 
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FIG. 3. Chondrocyte density in agarose gel measured as 
cell number/unit area. Cell density increased rapidly 
during the first 2-3 weeks of culture and stabilized over 
the remaining 9-10 weeks of culture. Total cell number 
increased 2.6 times during the culture period. 
compared with day 1 cultures. On a per-cell basis, 
the type VI collagen deposition appeared to 
decrease during the first month of culture, while 
the net increase in deposition was 2.7-fold by the 
end of the culture period. The reason for this 
observation, as identified by cell tracker dye and 
immunohistochemistry, was that one subpopu- 
lation of chondrocytes consistently sequestered 
low levels of type VI collagen, but were actively 
proliferating active during the first phase of 
culture. 
I L -1  TREATMENT 
Immunohistochemical staining of IL-1 treated 
cultures is shown in Fig. 5(a) (b). Cell clusters 
typical of control cultures at 17 days were 
surrounded by a stippled type VI co l lagen 
sequestration pattern [Fig. 5(a)]. While s imi lar  to 
the pattern seen in Fig. l(a)-(b), the cells in these 
clusters frequently shared a narrow pericellular 
margin with neighboring chondrocytes. In con- 
trast, substantial deposits of type VI collagen were 
observed around the cells in clusters of IL-1 treated 
cultures [Fig. 5(b)]. In particular, each cell was 
associated with a distinct pericellular matrix 
rich in type VI collagen, the overall integrity of 
the cluster being maintained by the integrated 
architecture of overlapping microenvironments 
[Fig. 5(b)]. 
The cell density of IL-I~ treated cultures was 
not significantly different from control cultures 
(data not shown), indicating that IL-la did not 
stimulate the rate of chondrocyte proliferation 
over the 2-week incubation period. In contrast, the 
immunodot binding analysis showed that IL-I~ 
treatment at concentrations of 0.5 and 5.0 ng/ml, 
both produced a marked increase in type VI 
collagen sequestrat ion (Fig. 6). Although little 
change was evident after 3 days exposure to IL-I~, 
a significant increase in type VI collagen depo- 
sition was observed at both 7 and 14 days of IL-la 
treatment (Fig. 6). No significant differences were 
identified between cultures treat,ed with 0.5 or 
5.0 ng/ml IL-la. 
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FIG. 4. Immunodot binding analysis of cell-associated 
type VI collagen. Two phases of type VI collagen 
deposition could be identified, a primary phase in the 
first 4 weeks characterized by low levels of type VI 
collagen deposition, followed by a secondary phase 
characterized by a steady increase in type VI collagen 
sequestration. Type VI collagen levels had increased 
fivefold at 12 weeks compared with day 1 culture. 
Discuss ion 
Confocal immunohistochemistry in combination 
with specific biochemical analysis has shown that 
articular chondrocytes cultured in agarose gel 
initiate type VI collagen deposition upon plating 
and continue pericellular matrix sequestration i  
a time dependent manner. In particular, confocal 
microscopy and image analysis revealed a thin, 
stippled layer of type VI collagen which forms on 
the cell surface during the first week of culture. 
After 6 weeks in culture, a more compact, 
'cargo-net-like', structure progressively encapsu- 
lated the chondrocyte and ultimately formed a 
series of concentric layers which defined the 
collagenous pericellular matrix by 12 weeks of 
culture. Similar pericellular staining patterns 
have been reported for the proteoglycans and 
fibrillar collagens produced by chondrocytes in 
agarose [25], alginate [25, 35] and  high-density 
cultures [36], but none of these studies have 
focused specifically on type VI collagen, which we 
FI~. 5. Digital confocal images of chondrocytes cultured in agarose gel for 17 days and labeled with anti-type VI 
collagen antibody. (a) A single optical section through atypical chondrocyte cluster in culture without IL-I~ treatment. 
(Jells at the periphery of the cluster formed a strong stippled pattern of type VI collagen sequestration, while cells 
in the center showed a weak pericel]ular reaction. Bar = 10 ]lm. (b) A single optical section through a chondrocyte 
cIuster after 14 days exposure to IL-la (5.0 ng/ml). A nmrked increase in the width and intensity of type VI collagen 
sequestration was evident around cells in the cluster. Bar = 10 pm. 
consider an accurate marker of chondron mor- 
phology in adult tissue [3, 11]. Colocalization 
studies are now in progress using a range of matrix 
antibodies. These studies suggest hat the fibrillar 
collagens are more closely associated with the type 
VI collagen microenvironment than the gly- 
c osaminoglycans and proteoglycans, which have 
been found to have a significantly broader 
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Fia. 6. The immunodot binding analysis of cell 
associated type V1 collagen in cultures treated with 
IL-I~ at concentrations of 0.5 (~) and 5.0 (~) ng/ml. 
Comparison with untreated controls (m) reveals ignifi- 
cant increases in type VI collagen deposition at both 7 
and 14 days of IL-I:~ treatment (*P < 0.05). 
pericellular distribution (Chang and Poole, in 
preparation). However, it should be emphasized 
that a heterogeneous population of art icular 
chondrocytes was used in these studies, and a 
distinct subpopulation of cells was identified 
which showed minimal type VI collagen sequestra- 
tion. The possibility that this subpopulation of 
cells may derive from the superficial layer, 
previously shown to yield chondrocytes with a 
limited capacity to form a pericellular matrix 
in vitro [31], is currently being examined in more 
homogeneous cultures of superficial and deep layer 
chondrocytes. 
Specific biochemical analysis confirmed the 
immediate sequestration and progressive accumu- 
lation of type VI collagen in chondrocyte agarose 
culture. However, the correlation between the 
cell-density data and analysis of cell associated 
type VI collagen suggests two distinct phases in 
the pericellular sequestration of type VI collagen. 
The primary phase, which occurred over the first 
2-4 weeks of culture, was characterized by rapid 
cell proliferation (as measured by cell density) and 
a comparatively low rate of type VI collagen 
sequestration. In contrast, the secondary phase of 
activity was characterized by a marked reduction 
in the rate of chondrocyte proliferation and an 
equally marked increase in type VI collagen 
sequestration. Thus, after 12 weeks of culture, cell 
density increased 2.6-fold, while pericellular type 
V[ collagen increased to five times the level of day 
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1 controls. Further studies are in progress which 
will attempt to correlate the rate of type VI 
collagen synthesis with the rate of pericellular 
sequestration. 
Previous data from cultured fibroblasts have 
also shown that type VI collagen was initially 
expressed during the later part of the proliferative 
phase, and that a large proportion of the threefold 
increase in newly synthesized type VI collagen was 
deposited into the cell-associated matrix [33]. A 
similar profile of type VI collagen mRNA ex- 
pression has recently been reported in fibroblasts 
during wound healing [37], while our own data 
suggests that the initial proliferative phase was 
followed by a period of active type VI collagen 
sequestration to produce a complete pericellular 
matrix enclosing the chondrocyte. These results 
are consistent with the view that connective tissue 
cells such as fibroblasts and chondrocytes first 
initiate proliferation which is then followed by 
high rates of type VI collagen synthesis when the 
normal interactions between the cells and their 
extracellular matrix are destroyed or disrupted by 
mechanical or enzymatic perturbation. 
The mechanisms by which synthesized type VI 
collagen is sequestered and retained at the cell 
surface were not examined in this study. However, 
published reports uggest that a range of cell-sur- 
face receptors, including the integrins [14, 38], the 
hyaluronan receptor CD44 [20,39], and the 
developmental receptor NG2 [16], could potentially 
mediate the interaction between the chondrocyte 
and type VI collagen [11]. A specific cell-surface 
localization of type VI collagen was identified in 
this study, and in conjunction with previous 
studies on isolated chondrons, suggests that type 
VI collagen could mediate both cell-matrix and 
matrix-matrix interactions critical for the main- 
tenance of the pericellular superstructure and the 
macromolecular heterogeneity of the pericellular 
microenvironment in adult articular cartilage 
[3,11]. We speculate that type VI collagen, 
synthesized and secreted in a pre-assembled 
tetrameric form [40], is retained at the cell surface 
by integral membrane receptors and that the 
sequestration and lateral assembly of type VI 
collagen may lead to the progressive differen- 
tiation of a pericellular microenvironment around 
each chondrocyte. We argue that this adult 
chondrocyte-agarose gel culture system represents 
an appropriate model with which to examine the 
role of type VI collagen in the formation, 
maintenance and remodeling of the pericellular 
microenvironment typical of mature and os- 
teoarthritic hondrocytes. 
IL-I~, an important mediator of osteoarthritis, 
has been characterized in the synovial fluid of 
osteoarthritic joints [41, 42], and is known to be 
synthesized by both synoviocytes and chondro- 
cytes in vivo and in vitro [43,44]. In the 
experiments reported here, IL-la stimulated the 
pericellular sequestration of type VI collagen, 
presumably by up-regulation of type VI collagen 
synthesis. Confocal microscopy confirmed the 
increased accumulation of type VI collagen in 
IL-la treated cultures, with some cells forming 
clusters similar to those previously seen in 
osteoarthritic cartilage labeled for type VI colla- 
gen (Poole, personal observation). 
It is now well established that IL-1 promotes 
cartilage catabolism by stimulating the production 
of prostaglandin E2and neutral metalloproteinases 
including collagenase, stromelysin and plasmino- 
gen activator [24,45,46]. Simultaneously, IL-1 
down-regulates proteoglycan production [25, 47] 
and modulates collagen synthesis [48-50]. In 
human chondrocyte cultures for example, IL-1 
down-regulates the expression of type II and IX 
collagens, but increases the synthesis of type I and 
III collagens, signaling a marked change in the 
expression of the chondrocyte phenotype [22]. 
However, in contrast o the fibrillar collagens, 
studies on the effect of IL-1 .on type VI collagen 
synthesis are limited. Bathon and co-workers [51] 
recently demonstrated an IL-1 induced suppression 
of type VI collagen mRNA expression in cultured 
human synovial fibroblast-like cells. This obser- 
vation is at variance with the reported increase in 
type VI collagen in the synovium of arthritic joints 
[52], and stands in marked contrast o the IL-1 
induced increase in pericellular type VI collagen 
sequestration reported in this study. Thus, it is 
entirely possible that IL-1 regulation of type VI 
collagen metabolism ay be in part cell specific. 
Irrespective of these arguments, the significant 
increase in pericellular type VI collagen sequestra- 
tion induced by I1-1 is consistent with studies 
reporting elevated levels of type VI collagen in 
osteoarthritic cartilage [28-30], and clearly high- 
lights an important functional role for type VI 
collagen during the pericellular remodeling associ- 
ated with osteoarthritic degeneration [53]. 
One possible xplanation for these results is that 
the IL-1 induced suppression of normal proteogly- 
can and fibrillar collagen synthesis i coupled with 
a stimulation of type VI collagen production to 
ensure continued cell-matrix integrity during 
osteoarthritic remodeling. Alternatively, type VI 
collagen may preferentially accumulate around 
the cell because it is endowed with a remarkable 
degree of resistance to the metalloproteinases 
induced by IL-1 [26, 27]. Type VI collagen however, 
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is catabolized by the serine proteases [27]. IL-1 
stimulates the activity of tissue plasminogen 
activator in cart i lage explant cultures, while 
simultaneously increasing the mRNA expression 
of the serine proteinase inhibitor, plasminogen 
activator inhibitor-1 (PAL1) [54]. In fibroblasts, 
IL-1 stimulates a second plasminogen act ivator 
inhibitor, PAI-2 [55], while the protease nexin, 
which inhibits serine proteinases, is up-regulated 
by IL-1 in both chondrocyte and synovial fibroblast 
cultures [49]. It is possible, therefore, that type VI 
collagen's resistance to metal loproteinase attack, 
coupled with the protective ffect of IL-1 induced 
serine proteinase inhibitors, provides an appropri- 
ate environment for the increased pericel lular 
accumulation of type VI collagen. 
In summary, confoca l  microscopy and image 
analysis have demonstrated the spatial and 
temporal differentiation of type v i  collagen in the 
pericellular microenvironment of adult art icular 
chondrocytes cultured long-term in agarose gel. 
Concurrent biochemical analysis confirmed a 
fivefold increase in pericellular type VI collagen 
accumulation over the culture period, and an IL-1 
induced increase in the pericellular sequestration 
of type VI collagen. This model is now being used 
to examine the role of fibrillar collagens, glyco- 
proteins, proteoglycans and glycosaminoglycans 
during the development and differentiation of the 
pericellular microenvironment, relating the 
characteristic distribution of type VI collagen to 
that of structural macromolecules previously 
identified in the chondrons of normal and 
osteoarthrit ic cartilage. 
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